Clinical trials
Trials in Reunion with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
49 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2015 | 1 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 7 |
| 2022 | 7 |
| 2023 | 8 |
| 2024 | 6 |
| 2025 | 8 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 24 |
| Recruiting | 17 |
| Unknown status | 4 |
| Not yet recruiting | 1 |
| Active, not recruiting | 1 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Centre Hospitalier Universitaire de la Réunion | 32 |
| Clinique Saint-Vincent | 2 |
| Universite de La Reunion | 2 |
| Association de Musicothérapie Applications et Recherches Cliniques | 1 |
| Centre Hospitalier Departemental Vendee | 1 |
| Centre Hospitalier Universitaire de Nice | 1 |
| Centre Hospitalier Universitaire de Nīmes | 1 |
| Clinique Sainte Clotilde | 1 |
| GCS-CCOMS | 1 |
| Institut Curie | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lipodystrophy | 3 |
| Neoplasms | 3 |
| Genetic Predisposition to Disease | 2 |
| Leptospirosis | 2 |
| Lipodystrophy, Familial Partial | 2 |
| Adenocarcinoma | 1 |
| Agnosia | 1 |
| Anxiety Disorders | 1 |
| Appendicitis | 1 |
| Attention Deficit Disorder with Hyperactivity | 1 |
Trials
Showing 26 to 49 of 49. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.